Celebrity Gossip Never Looked So Good ®
YBF on Twitter YBF on Facebook YBF on Instagram Feed

Pharmaceutical Companies Receive $1.95 BILLION To Produce Coronavirus Vaccine By December + There’s A Mask That Supposedly ‘Deactivates’ COVID-19

​ ​ ​ ​

The U.S. government is coughing up HELLA cash for a COVID-19 vaccine to be here by the end of the year. Deets on the billions that were dropped for the vaccine, plus information about a mask that supposedly “deactivates” the virus inside….

Could a vaccine for COVID-19 be here by the end of the year? Possibly.

The United States government is coughing up big bucks to have the Coronavirus vaccine available by the end of the year as the world races to figure out how to stop the virus. When the pandemic first began, scientists said we likely wouldn’t receive a vaccine until 2021. That all could change.

The NY Times reports the Trump administration made one of the largest investments yet for a COVID-19 vaccine. The government is offering a whopping $1.95 billion for the vaccine by December. Pfizer and BioNTech, a German biotechnology company, were offered nearly $2 billion for 100 million doses by December. Wow!

Under the deal, the government would obtain the first batch of vaccines, which equals out to about $20 per dose with the rights to acquire 500 million more, or 600 million total. Americans will reportedly receive the vaccine for free. The pharmaceutical companies wouldn’t get paid the nearly $2 billion until the Food and Drug Administration approves it and the first 100 million doses are delivered.

More deets on the contract below:

The contract is part of what the White House calls the Warp Speed project, an effort to drastically shorten the time it would take to manufacture and distribute a working vaccine. So far, the United States has put money into more than a half dozen efforts, hoping to build manufacturing ability for an eventual breakthrough.

Europe has a parallel effort underway. Germany recently took a 23 percent stake in a German firm, CureVac, that President Trump once tried to lure to American shores in hopes that its vaccine, if successful, would be distributed in the United States first. A European-led fund-raising effort in May brought $8 billion in pledges from the world’s governments, philanthropists and leaders for coronavirus vaccine research, even with the United States sitting out the conference.

China, meantime, has militarized the effort: Researchers associated with the Academy of Military Medical Sciences have developed one of China’s leading vaccine candidates, and another Chinese firm, Sinopharm Group, announced in June that it was beginning Phase 3 trials in the United Arab Emirates.

The Pfizer contract, an agreement to ensure the pharmaceutical giant has a market for its work, is the biggest splash yet by the Americans. No vaccine has yet been developed, and it is not clear whether the Pfizer version will work. But if the vaccine being produced by Pfizer and BioNTech, the German firm, proves to be safe and effective in clinical trials, the companies say they could manufacture those first 100 million doses by the end of the year.

The federal government will also pay Maryland-based company Novavax $1.6 billion to expedite the development of a Coronavirus vaccine.

“We’ve been committed to making the impossible possible by working tirelessly to develop and produce in record time a safe and effective vaccine to help bring an end to this global health crisis,” Dr. Albert Bourla, Pfizer’s chairman and chief executive officer, said in a news release.

These companies are receiving billions of dollars to compete against one another to develop a Coronavirus vaccine. Let’s hope the pharmaceutical companies follow best practice rules to find a vaccine that will kill off the virus that crippled the world at one point.

In other Coronavirus news…

Many jurisdictions are adopting mandatory mask polices in enclosed public spaces, intended to delay the spread of the COVID-19 disease. So, that means Americans need masks! But, not just any old mask.

Now, there are claims of a new mask that can "deactivate" the virus. According to a press release, the University of Toronto has confirmed the virus "cannot be recovered after being applied to the TrioMed Active mask. The mask's external surface deactivates >99% of the Coronavirus suspension within minutes."


According to the press release:

The TrioMed Active Mask type IIR surgical mask incorporates TrioMed's technology and provides an advanced level of active protection for healthcare workers and the general population. The patented antimicrobial technology is at the core of the company's entire line of medical products such as wound dressings, medical tapes, gloves, headwear, gowns and other personal protective equipment sold globally.

A study published in the American Journal of Infection Control established that people touch their face 23 times per hour on average1. Furthermore, the coronavirus that causes Covid-19 remains present and infectious on the outer layer of masks for up to 7 days, according to a study published in The Lancet Microbe2. In addition to the warnings issued by governmental authorities pertaining to self-contamination by touching one's mask, these two scientific publications further demonstrate the major deficiency in the level of protection for all wearers of current masks.

"The TrioMed Active Mask is the first and only respiratory protection that is scientifically proven to deactivate the virus causing Covid-19, therefore drastically reducing the risk of contamination for the wearer", says Pierre Jean Messier, founder and CEO of i3 Biomedical Inc. "Our company spent years and millions of dollars to develop this interactive antimicrobial technology. The resulting products are used by the medical community around the world and have been tested by independent laboratories to kill numerous microbes, such as MRSA, VRE, E-Coli, Staphylococcus Aureus, Influenza Virus and now SARS-CoV-2. This third-party scientific testing confirms TrioMed's leading position in medical antimicrobial technology available in the global fight against Covid-19."

Right now, the mask is only being sold and shipped to Canadian residents. If they expand their sales to the U.S., would you cop one?


Photo: Drazen Zigic/Shutterstock.com

​ ​
​ ​
​ ​ ​
​ ​



Log in to post a new comment

Log in to post a new comment

Sign in with Facebook